Guidance for the use and prescribing of PCSK9 inhibitors

Primary care guidance for the prescribing and supply of Inclisiran

Inclisiran for the treatment of familial or non-familial hyperlipidaemia in secondary prevention of CVD

Summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease

NHS South West Strategic Clinical Network - Top tips for managing AF

Clinical guidelines for Secondary Prevention after Stroke or TIA

Inhixa (enoxaparin biosimilar) Information sheet

1. Propranolol is included for the management of conditions such as thyrotoxicosis, migraine and anxiety. The modified-release capsules should be reserved for patients where a once daily preparation is essential for compliance.

2. Labetalol is included for the treatment of hypertension in pregnancy, whilst the injectable preparation may be used in a hypertensive crisis.

3. Metoprolol is a short-acting agent which may be used in secondary care post myocardial infarction and as an adjunct in heart failure (unlicensed indication).

4. The CSM advises that the use of SOTALOL should be limited to the treatment of ventricular arrhythmias or prophylaxis of supraventricular arrhythmias. Treatment with sotalol should commence only under specialist supervision.

5. Both Bisoprolol (a once daily long-acting beta-blocker) and Carvedilol (a twice daily beta-blocker) are used as adjuncts in heart failure. See NICE Clinical Guideline on Heart Failure